Quintiles Announces Clinical Research Partnership with the University Malaya Medical Centre

摘要

Quintiles, a fully integrated biopharmaceutical services compam offering clinical, commercial, consulting and capital solution worldwide, announced a strategic alliance agreement with the y Malaya Medical Centre (UMMC) as part of its unique Prime Site program - an initiative focused on accelerating the development of new and more effective medicines. The UMMC is the first Prime Site in Asia for Quintiles, adding to its existing four other sites located in the US, Europe and Africa.